Prospera Financial Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-724
Closed -$70K 1723
2020
Q3
$70K Sell
724
-1,144
-61% -$132K 0.03% 514
2020
Q2
$229K Sell
1,868
-1,245
-40% -$141K 0.02% 513
2020
Q1
$273K Sell
3,113
-1,124
-27% -$119K 0.03% 412
2019
Q4
$443K Buy
4,237
+1,557
+58% +$175K 0.03% 401
2019
Q3
$308K Sell
2,680
-769
-22% -$117K 0.03% 424
2019
Q2
$595K Buy
3,449
+945
+38% +$163K 0.07% 252
2019
Q1
$420K Buy
+2,504
New +$373K 0.14% 197
2014
Q4
Sell
-5,580
Closed -$451K 326
2014
Q3
$451K Buy
+5,580
New +$494K 0.12% 139

Other funds holding GWPH

Prospera Financial Services's GWPH Position: Q4 2020 in Review

Prospera Financial Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 724 shares — an estimated $70K sold.

Prospera Financial Services first reported a position in GWPH in Q3 2014 and held it in 8 quarters. The position peaked at $595K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Prospera Financial Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Prospera Financial Services sold 724 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $70K.
  • Prospera Financial Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 8 quarters.
  • Prospera Financial Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $595K in Q2 2019.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Prospera Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.